These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31479592)

  • 21. New synthetic cannabinoids carrying a cyclobutyl methyl side chain: Human Phase I metabolism and data on human cannabinoid receptor 1 binding and activation of Cumyl-CBMICA and Cumyl-CBMINACA.
    Haschimi B; Grafinger KE; Pulver B; Psychou E; Halter S; Huppertz LM; Westphal F; Pütz M; Auwärter V
    Drug Test Anal; 2021 Aug; 13(8):1499-1515. PubMed ID: 33788409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MS.
    Hutter M; Broecker S; Kneisel S; Franz F; Brandt SD; Auwarter V
    Curr Pharm Biotechnol; 2018; 19(2):144-162. PubMed ID: 29745330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection and characterization of the new synthetic cannabinoid APP-BINACA in forensic casework.
    Krotulski AJ; Mohr ALA; Diamond FX; Logan BK
    Drug Test Anal; 2020 Jan; 12(1):136-144. PubMed ID: 31788963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occupational transdermal poisoning with synthetic cannabinoid cumyl-PINACA.
    Dobaja M; Grenc D; Kozelj G; Brvar M
    Clin Toxicol (Phila); 2017 Mar; 55(3):193-195. PubMed ID: 28084855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance characteristics of an ELISA screening assay for urinary synthetic cannabinoids.
    Spinelli E; Barnes AJ; Young S; Castaneto MS; Martin TM; Klette KL; Huestis MA
    Drug Test Anal; 2015 Jun; 7(6):467-74. PubMed ID: 25167963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of main metabolites of XLR-11 and its thermal degradation product in human hepatoma HepaRG cells and human urine.
    Kanamori T; Kanda K; Yamamuro T; Kuwayama K; Tsujikawa K; Iwata YT; Inoue H
    Drug Test Anal; 2015 Apr; 7(4):341-5. PubMed ID: 25600155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection and quantification of new designer drugs in human blood: Part 1 - Synthetic cannabinoids.
    Ammann J; McLaren JM; Gerostamoulos D; Beyer J
    J Anal Toxicol; 2012 Jul; 36(6):372-80. PubMed ID: 22593567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral Fluid vs. Urine Analysis to Monitor Synthetic Cannabinoids and Classic Drugs Recent Exposure.
    Blandino V; Wetzel J; Kim J; Haxhi P; Curtis R; Concheiro M
    Curr Pharm Biotechnol; 2017; 18(10):796-805. PubMed ID: 29173162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gas and liquid chromatography-mass spectrometry detection of the urinary metabolites of UR-144 and its major pyrolysis product.
    Grigoryev A; Kavanagh P; Melnik A; Savchuk S; Simonov A
    J Anal Toxicol; 2013 Jun; 37(5):265-76. PubMed ID: 23592743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library search.
    Wohlfarth A; Scheidweiler KB; Chen X; Liu HF; Huestis MA
    Anal Chem; 2013 Apr; 85(7):3730-8. PubMed ID: 23458260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism.
    Hutter M; Moosmann B; Kneisel S; Auwärter V
    J Mass Spectrom; 2013 Jul; 48(7):885-94. PubMed ID: 23832945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of a selection of synthetic cannabinoids and metabolites in urine by UHPSFC-MS/MS and by UHPLC-MS/MS.
    Berg T; Kaur L; Risnes A; Havig SM; Karinen R
    Drug Test Anal; 2016 Jul; 8(7):708-22. PubMed ID: 26304456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Fast and Comprehensive Analysis of 32 Synthetic Cannabinoids Using Agilent Triple Quadrupole LC-MS-MS.
    Borg D; Tverdovsky A; Stripp R
    J Anal Toxicol; 2017 Jan; 41(1):6-16. PubMed ID: 27681343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
    Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
    Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA.
    Banister SD; Adams A; Kevin RC; Macdonald C; Glass M; Boyd R; Connor M; McGregor IS; Havel CM; Bright SJ; Vilamala MV; Lladanosa CG; Barratt MJ; Gerona RR
    Drug Test Anal; 2019 Feb; 11(2):279-291. PubMed ID: 30151911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro metabolism of the synthetic cannabinoids CUMYL-PINACA, 5F-CUMYL-PINACA, CUMYL-4CN-BINACA, 5F-CUMYL-P7AICA and CUMYL-4CN-B7AICA.
    Staeheli SN; Poetzsch M; Veloso VP; Bovens M; Bissig C; Steuer AE; Kraemer T
    Drug Test Anal; 2018 Jan; 10(1):148-157. PubMed ID: 28885775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous detection of 93 synthetic cannabinoids by liquid chromatography-tandem mass spectrometry and retrospective application to real forensic samples.
    Hess C; Murach J; Krueger L; Scharrenbroch L; Unger M; Madea B; Sydow K
    Drug Test Anal; 2017 May; 9(5):721-733. PubMed ID: 27400642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comprehensive library-based, automated screening procedure for 46 synthetic cannabinoids in serum employing liquid chromatography-quadrupole ion trap mass spectrometry with high-temperature electrospray ionization.
    Huppertz LM; Kneisel S; Auwärter V; Kempf J
    J Mass Spectrom; 2014 Feb; 49(2):117-27. PubMed ID: 24677304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity-Based Detection of Cannabinoids in Serum and Plasma Samples.
    Cannaert A; Storme J; Hess C; Auwärter V; Wille SMR; Stove CP
    Clin Chem; 2018 Jun; 64(6):918-926. PubMed ID: 29559524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity-Based Detection of Consumption of Synthetic Cannabinoids in Authentic Urine Samples Using a Stable Cannabinoid Reporter System.
    Cannaert A; Franz F; Auwärter V; Stove CP
    Anal Chem; 2017 Sep; 89(17):9527-9536. PubMed ID: 28771321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.